Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 12/20 | 0.44 |
| ▸ | FAAH | O00519 | 5/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | XBP1 | P17861 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15577150 | 0.76 | MGLL (0.38) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL20528097 | 0.72 | MGLL (0.46) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL88581 | 0.72 | CASP3 (0.48) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL2496082 | 0.68 | MGLL (0.42) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL6537077 | 0.68 | MGLL (0.48) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL1955696 | 0.68 | MGLL (0.42) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL4989707 | 0.67 | MGLL (0.46) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL28572221 | 0.66 | MGLL (0.42) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL114195 | 0.66 | MGLL (0.58) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL756295 | 0.64 | AKR1B1 (0.43) | MGLLFAAHALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230310624-A1 | AFFIBODY-CYTOTOXIN CONJUGATE FOR ACTIVE TARGETED THERAPY OF TUMORS, NANOPARTICLE THEREOF, PREPARATION METHOD THEREOF AND APPLICATION THEREOF | SHANGHAI JIAOTONG UNIVERSITY (CN) | 2023-10-05 | — | — | US | disclosed |
| EP-4230224-A1 | AFFIBODY-CYTOTOXIN CONJUGATE USED FOR ACTIVE TUMOR TARGETING THERAPY, AND NANOPARTICLES, PREPARATION METHOD, AND APPLICATION THEREOF | SHANGHAI JIAOTONG UNIVERSITY (CN) | 2023-08-23 | — | — | EP | disclosed |
| CN-112220931-B | Affinity body-cytotoxin conjugate for active targeted therapy of tumor, nanoparticle thereof, preparation method and application | 上海交通大学 | 2022-03-08 | — | — | CN | disclosed |
| EP-3862389-B1 | CHLOROPRENE RUBBER COMPOSITION AND VULCANIZATION MOLDED BODY | DENKA COMPANY LTD (JP) | 2022-02-23 | — | — | EP | disclosed |
| US-20220002526-A1 | CHLOROPRENE RUBBER COMPOSITION AND VULCANIZATION MOLDED BODY | DENKA COMPANY LIMITED (JP) | 2022-01-06 | — | — | US | disclosed |
| EP-3862389-A1 | CHLOROPRENE RUBBER COMPOSITION AND VULCANIZATION MOLDED BODY | Denka Company Limited (JP) | 2021-08-11 | — | — | EP | disclosed |
| CN-112220931-A | Affinity body-cytotoxin conjugate for active targeted therapy of tumor, nanoparticle thereof, preparation method and application | 上海交通大学 | 2021-01-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230310624-A1 | AFFIBODY-CYTOTOXIN CONJUGATE FOR ACTIVE TARGETED THERAPY OF TUMORS, NANOPARTICLE THEREOF, PREPARATION METHOD THEREOF AND APPLICATION THEREOF | ASGR1, FCGR2A, FCGR1A | MGLL 4538/4885FAAH 885/4885ALDH1A1 2131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.